Both branded and generic products are subject to counterfeiting
Drug counterfeiting has increased significantly in Latin America in recent years. This new Latin America perception study by Sanofi was conducted in December 2016 and is based on the responses of over 7,000 individuals from Argentina, Brazil, Guatemala, Ecuador, Peru, Mexico and Colombia. The purpose of the questions asked is to understand the level of awareness and perception of Latin Americans of the phenomenon of drug counterfeiting.
The study shows that 59% of the population questioned associates counterfeiting with drugs, more than clothing, high-tech objects and luxury goods. Colombia has the highest association rate (71%) while the lowest is in Brazil (32%), where counterfeiting is more often associated with luxury clothing and brands. 91% on average in the 7 countries had heard of counterfeit medicines.
Despite the fact that 91% have already heard about counterfeit medicines, only 62% of respondents consider that they are a danger and 36% consider that they are only “potentially” dangerous.